Engineered T Cells Targeting Hepatitis B Antigen Show Glimmer of Benefit in Advanced Liver Cancer
A case report details how HBsAg-targeted TCR-engineered T cells produced a manageable grade 3 cytokine release syndrome and a transient ...
A case report details how HBsAg-targeted TCR-engineered T cells produced a manageable grade 3 cytokine release syndrome and a transient ...
An editorial from Clinical Cancer Bulletin maps the converging technologies — TCR-T cells, cancer organoids, multi-specific antibody-drug conjugates, nanotechnology, and ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine